| Title: A Rational Approach to Developing Oral Extended Release Products |
|---|
| Speaker: Dr. Avinash Nangia, Founder & Chief Scientific Officer, Vaunnex Inc. |
|---|
| Location: |
Hanover Marriott |
|---|
| 1401 Route 10 East |
| Whippany, New Jersey 07981 |
| Phone: 1-973-538-8811 |
| Date: | November 19, 2009 |
|---|
| Registration/Social Hour 5:30 PM |
| Dinner 6:30PM |
| Presentations 7:30PM |
| Reservations: |
Make reservations via our website. You can also prepay by using the PayPal option. Payment on the day of the event(s) can only be conducted using cash, check, or money order. Credit cards or debit cards will not be accepted.
Please provide the following information:
* Name
* Company
* Phone Number
* E-mail
* Indicate if you would prefer a vegetarian meal |
|---|
| Please Note: |
ADVANCED REGISTRATION WILL END 7:00 PM ON TUESDAY, NOVEMBER 17. AFTER THAT TIME, YOU MUST REGISTER IN PERSON
* Register on-line and paid online by PayPal: $75
* Register at meeting (Walk-in): $80
* In-Between-Position/Student with ID: $40
HINT: If paying via PayPal, hit the "CONTINUE" button to enter your credit card information. |
|---|
| Sponsored by: |
|
|---|
| Abstract: |
A Rational Approach to Developing Oral Extended Release Products
The pharmaceutical industry must generate novel, effective and safe therapeutics that address unmet clinical
need and at a reasonable price. Developing a new oral extended release (ER) product presents formidable
scientific, medical and regulatory challenges. This presentation will review the challenges faced by the
development scientists as a background to proposing a rational approach to drive future ER product
development. This new “truth-seeking” approach surpasses the conventional paradigm by incorporating
modeling/simulation, understanding of the disease state, clinical endpoint and drug toxicity profile.
Synergistic use of these elements along with biopharmaceutical properties of the drug and GI transit
behavior of different oral delivery technologies will help in developing commercially viable oral ER therapeutics. |
|---|
| Bio: |
Dr. Avinash Nangia, Founder & Chief Scientific Officer, Vaunnex Inc.
Dr. Avinash Nangia currently is the chief scientific officer at Vaunnex Inc, a boutique pharmaceutical
company involved in the development of niche extended release products. He has over 18 years of experience
in the field of drug delivery, primarily in oral controlled release systems. In his career, he has successfully
taken numerous drugs from development to market while holding research management positions in both small
and large multi-national pharmaceutical companies. During his career, Dr. Nangia has worked in the research
and product development groups at Glaxo SmithKline, ALZA Corporation (a Johnson & Johnson company) and
Watson Pharmaceuticals. In his most recent position at Spherics Pharmaceuticals Inc., he was senior vice
president of research and development group responsible for developing neurological products based on
its proprietary targeted drug delivery technologies.
He has contributed to the development of over a dozen pharmaceutical products including 5 oral
extended-release brand products and various oral drug delivery technologies (Procise™, L-OROS™, SCOT™,
BIOGIT™, BIOROD™, POLYROD™ and Spheromer™).
Dr. Nangia was trained as a pharmacist and has PhD in Pharmaceutical Sciences from the University of Otago,
New Zealand and conducted Post-Doctoral Fellowship at the University of California, San Francisco.
Dr. Nangia has authored over 45 peer reviewed publications and is an inventor of over 40
issued/pending patents in the areas of product development and novel drug delivery systems. He is a member of
the American Association of Pharmaceutical Scientists, the Controlled Release Society, the American College
of Clinical Pharmacology, and the American Academy of Neurology. |
|---|
| DIRECTIONS TO: Hanover Marriott, NJ |
|---|
| Address: 1401 Route 10 E
Whippany, New Jersey 07981 USA
Phone: 1-973-538-8811
Fax: 1-973-538-0291
Toll-free: 1-800-242-8681 |
| From North NJ, CT and Upstate NY:
1. Take I-80 West to Exit 43 A-B for I-287 South toward Morristown.
2. Continue on I-287 South and take Exit 39B merge right to RT-10 West toward Dover.
3. Take Exit toward Cedar Knolls/ Ridgedale Ave.
4. Merge onto Dryden Way
5. Take the ramp onto RT-10 East. Hotel will be on your right.
From NY City, PA, and South NJ:
1. Take I-287 North.
2. Take Exit 39 to RT-10 West toward Dover.
3. Take Exit toward Cedar Knolls/ Ridgedale Ave.
4. Merge onto Dryden Way
5. Take the ramp onto RT-10 East. Hotel will be on your right. |
|
